LS
BMRA icon

Leelyn Smith’s Biomerica BMRA Stock Holding History

Leelyn Smith’s Portfolio BMRA Stock Details BMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-13
Closed – – 383
2021
Q3 		$0 Buy
+13
New +$427 ﹤0.01% 354

Other funds holding BMRA

GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FC
Fore Capital New York $338M AUM 10.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return
HIMC
Heritage Investors Management Corp Bethesda, Maryland $3.61B AUM 35.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $33.6B AUM 31.03% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return

Leelyn Smith's BMRA Position: Q4 2021 in Review

Leelyn Smith sold out of Biomerica (BMRA) in Q4 2021, closing a stake of 13 shares.

Leelyn Smith first reported a position in BMRA in Q3 2021 and held it in 1 quarter. The position peaked at $0 in Q3 2021. 24 funds tracked by Wall St. Rank hold BMRA as of Q4 2021.

  • Leelyn Smith reported no remaining Biomerica position as of Q4 2021 after selling out during the quarter.
  • Leelyn Smith sold 13 Biomerica shares in Q4 2021.
  • Leelyn Smith first reported a position in Biomerica in Q3 2021 and held it in 1 quarter.
  • Leelyn Smith's Biomerica position peaked at $0 in Q3 2021.
  • 24 funds tracked by Wall St. Rank held Biomerica as of Q4 2021.

Based on Leelyn Smith's 13F filing for Q4 2021, filed 14 Feb 2022.